|
Performance variable
|
Discrimination
|
Calibration
|
|---|
|
AUC
|
95% CI
|
H-L P-value
|
GiViTI P-value
|
|---|
|
Development cohort
|
|
APACHE II
|
0.86
|
0.84, 0.88
|
0.766
|
NA
|
|
SAPS II
|
0.86
|
0.84, 0.88
|
0.624
|
NA
|
|
SOFA
|
0.74
|
0.71, 0.76
|
0.001
|
NA
|
|
Reference *
|
0.85
|
0.83, 0.86
|
0.001
|
NA
|
|
Reference †
|
0.85
|
0.83, 0.87
|
0.001
|
NA
|
|
Validation cohort
|
|
APACHE II
|
0.83
|
0.81, 0.85
|
<0.001
|
<0.001
|
|
SAPS II
|
0.84
|
0.82, 0.86
|
0.058
|
0.014
|
|
SOFA
|
0.73
|
0.71, 0.76
|
<0.001
|
<0.001
|
|
Reference *
|
0.84
|
0.82, 0.86
|
<0.001
|
<0.001
|
|
Reference †
|
0.84
|
0.82, 0.86
|
<0.001
|
0.003
|
-
APACHE II Acute Physiology and Chronic Health Evaluation II; GCS Glasgow Coma Scale; ICU intensive care unit; NA not available; SAPS II Simplified Acute Physiology Score II; SOFA Sequential Organ Failure Assessment. *Reference model including age and GCS. † Reference model including age, GCS and premorbid functional status
